Wilcock GK - Search Results

1

Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease.

MacGowan SH, Wilcock GK, Scott M. MacGowan SH, et al. Among authors: wilcock gk. Int J Geriatr Psychiatry. 1998 Sep;13(9):625-30. doi: 10.1002/(sici)1099-1166(199809)13:9<625::aid-gps835>3.0.co;2-2. Int J Geriatr Psychiatry. 1998. PMID: 9777427 Clinical Trial.

2

Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype.

Allen SJ, MacGowan SH, Tyler S, Wilcock GK, Robertson AG, Holden PH, Smith SK, Dawbarn D. Allen SJ, et al. Among authors: wilcock gk. Neurosci Lett. 1997 Dec 12;239(1):33-6. doi: 10.1016/s0304-3940(97)00872-0. Neurosci Lett. 1997. PMID: 9547165

3

Assessment of the value of therapeutic monitoring of tacrine in Alzheimer's disease.

Roberts CJ, Ford JM, Truman CA, Scott M, Mäkelä PM, Wilcock GK. Roberts CJ, et al. Among authors: wilcock gk. Eur J Clin Pharmacol. 1998 Nov-Dec;54(9-10):721-4. doi: 10.1007/s002280050541. Eur J Clin Pharmacol. 1998. PMID: 9923574 Clinical Trial.

4

An evaluation of the efficacy and safety of tetrahydroaminoacridine (THA) without lecithin in the treatment of Alzheimer's disease.

Wilcock GK, Surmon DJ, Scott M, Boyle M, Mulligan K, Neubauer KA, O'Neill D, Royston VH. Wilcock GK, et al. Age Ageing. 1993 Sep;22(5):316-24. doi: 10.1093/ageing/22.5.316. Age Ageing. 1993. PMID: 8237620

5

The effect of white matter low attenuation on cognitive performance in dementia of the Alzheimer type.

Amar K, Bucks RS, Lewis T, Scott M, Wilcock GK. Amar K, et al. Among authors: wilcock gk. Age Ageing. 1996 Nov;25(6):443-8. doi: 10.1093/ageing/25.6.443. Age Ageing. 1996. PMID: 9003880

6

The -491A/T polymorphism of the Apolipoprotein E gene is associated with the ApoEepsilon4 allele and Alzheimer's disease.

Ahmed AR, MacGowan SH, Culpan D, Jones RW, Wilcock GK. Ahmed AR, et al. Among authors: wilcock gk. Neurosci Lett. 1999 Mar 26;263(2-3):217-9. doi: 10.1016/s0304-3940(99)00126-3. Neurosci Lett. 1999. PMID: 10213175

7

Low affinity nerve growth factor receptor binding in normal and Alzheimer's disease basal forebrain.

Treanor JJ, Dawbarn D, Allen SJ, MacGowan SH, Wilcock GK. Treanor JJ, et al. Among authors: wilcock gk. Neurosci Lett. 1991 Jan 2;121(1-2):73-6. doi: 10.1016/0304-3940(91)90652-a. Neurosci Lett. 1991. PMID: 1708488

8

Normal beta-NGF content in Alzheimer's disease cerebral cortex and hippocampus.

Allen SJ, MacGowan SH, Treanor JJ, Feeney R, Wilcock GK, Dawbarn D. Allen SJ, et al. Among authors: wilcock gk. Neurosci Lett. 1991 Sep 30;131(1):135-9. doi: 10.1016/0304-3940(91)90354-v. Neurosci Lett. 1991. PMID: 1791973

9

The diagnosis of vascular dementia in the light of the new criteria.

Amar K, Wilcock GK, Scott M. Amar K, et al. Among authors: wilcock gk. Age Ageing. 1996 Jan;25(1):51-5. doi: 10.1093/ageing/25.1.51. Age Ageing. 1996. PMID: 8670529

10

Treatment for Alzheimer's disease.

Wilcock GK. Wilcock GK. Int J Geriatr Psychiatry. 2000 Jun;15(6):562-5. Int J Geriatr Psychiatry. 2000. PMID: 10861924 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

249 results

Search Page

Filters